Related Experiment Videos
Monoamine oxidase in schizophrenia: an overview
Schizophrenia Bulletin
|January 1, 1980
Summary
Studies show decreased monoamine oxidase (MAO) enzyme activity in the platelets of chronic schizophrenia patients compared to controls. This finding suggests a potential role for MAO in the etiology of some schizophrenia forms.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Schizophrenia is a complex psychiatric disorder with multifactorial etiology.
- Monoamine oxidase (MAO) is an enzyme involved in neurotransmitter metabolism.
- Previous research has investigated the potential link between MAO and schizophrenia.
Purpose of the Study:
- To review existing studies on the role of monoamine oxidase (MAO) in schizophrenia.
- To examine the significance of altered MAO enzyme activity in schizophrenia patients.
Main Methods:
- Literature review of studies measuring monoamine oxidase (MAO) activity.
- Comparison of MAO enzyme activity in chronic schizophrenic patients versus control groups.
- Analysis of challenges in comparing MAO activity across different patient populations.
Main Results:
- The majority of studies report decreased platelet monoamine oxidase (MAO) enzyme activity in chronic schizophrenic patients.
- Variability in MAO activity measurements across different patient cohorts was observed.
Conclusions:
- Decreased platelet monoamine oxidase (MAO) activity is a consistent finding in chronic schizophrenia.
- This reduction in MAO activity may play an etiological role in specific subtypes of schizophrenia.